-The Indian Express Progress on non-communicable diseases should not be benchmarked against sustainable development goals. In the last week of September, India’s health ministry received the prestigious UN Inter-Agency Task Force Award for “outstanding contribution to the achievement of NCD (Non-Communicable Diseases) related SDG targets”. At the same time, a Lancet paper by the monitoring group, NCD Countdown 2030, contended that India will fall short of the NCD targets pertaining to SDGS....

-The Indian Express More transparency is needed for Indian society to have an informed debate about rising inequality In a recent study titled ‘Indian income inequality dynamics (1922-2014): From British Raj to Billionaire Raj?’ published on WID.world, we presented new estimates of the distribution of national income in India, from 1922, when the income tax was introduced, up to 2014. In this study, we systematically combine the best available data at hand...

-Down to Earth Income inequality makes agrarian crisis challenging; inequality is worse among farmers than the formal economy Economists Lucas Chancel and Thomas Piketty recently concluded after a long study that inequality is at its peak in India. It is embedded in popular conscience: “Top 1 per cent of earners captured 22 per cent of total income in the country.” Their study–covering consumption, government accounts and income tax data from 1922...

-The Hindu * What’s the problem? The year 2017 was marked by several farmers’ protests nationwide, with a few turning violent. Last month, in New Delhi, 184 farmer groups came together from Tamil Nadu, Maharashtra, Madhya Pradesh, Uttar Pradesh, Punjab and Telangana to take part in a ‘protest walk.’ The protest once again highlighted the plight of farmers and the extent of agrarian distress. The agriculture sector is characterised by instability in incomes...

-The Telegraph New Delhi: The World Health Organisation has announced a plan to approve generic versions of two expensive bio-therapeutic anti-cancer molecules in an effort to make them available to low and middle-income countries. It said it would invite manufacturers to submit applications for pre-qualification of biologically similar versions of rituximab, used to treat chronic lymphocytic leukaemia and non-Hodgkin's lymphoma, and trastuzumab, used to treat breast cancer. The pre-qualification process is a mechanism...